IDO2 and lung cancer: A smart peptide hydrogelator Nap‐T is designed to co‐deliver paclitaxel and indoleamine 2,3‐dioxygenase inhibitor GDC0919, achieving sustained drug release upon pyruvate kinase M2 phosphorylation for non‐small cell lung cancer treatment.